Virafosc

Virafosc (Foscarnet Sodium Hexahydrate) is an antiviral medication used for treating certain viral infections. It works by stopping the growth of viruses in the body. This intravenous solution is prescribed for conditions requiring antiviral therapy.

Virafosc is primarily used to treat cytomegalovirus (CMV) infections, including retinitis in immunocompromised patients. It may also be prescribed for herpes simplex virus (HSV) infections unresponsive to other treatments. This medication helps manage severe viral conditions by reducing viral replication.

Virafosc works by inhibiting viral DNA polymerase, which slows or stops the spread of the virus in the body. Patients may experience improved symptoms as the medication takes effect. Common effects include reduced viral load and alleviation of infection-related discomfort.

Virafosc should be handled with care, as it is intended for intravenous use only. Patients should inform their healthcare provider about any kidney issues or electrolyte imbalances before starting treatment. Regular monitoring of kidney function and electrolyte levels is recommended during therapy.

Virafosc may interact with other medications that affect kidney function or electrolyte balance. Caution is advised when combining it with drugs like diuretics or nephrotoxic agents. Alcohol and certain supplements may also impact its effectiveness or increase side effects.